PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2007

PHARMANIAGA BERHAD

Financial Year End

31/12/2007
Quarter3
Quarterly report for the financial period ended30/09/2007
The figureshave not been audited

Attachments

3Q2007.pdf
101 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2007
30/09/2006
30/09/2007
30/09/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
334,700
289,040
891,166
790,927
2Profit/(loss) before tax
31,915
10,675
54,326
27,852
3Profit/(loss) for the period
21,561
5,396
35,271
17,209
4Profit/(loss) attributable to ordinary equity holders of the parent
21,302
5,039
34,011
15,974
5Basic earnings/(loss) per share (sen)
19.92
4.71
31.80
14.93
6Proposed/Declared dividend per share (sen)
0.00
0.00
15.00
11.50
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.1400
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
A final tax exempt dividend of 15.0% (2006 : 11.5%) on 106,963,188 (2006 : 106,958,888) ordinary shares of RM1.00 each in respect of the previous financial year amounting to RM16,044,478 (2006 : RM12,300,272) was paid on 13 July 2007.

The Directors do not recommend any payment of interim dividend for the current financial period ended 30 September 2007 (2006 : nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced22 Nov 2007  
CategoryFinancial Results
Reference NoPB-071120-34547